"Evaluating the biological effects of nanoparticles is a hugely complex task, and it is not commonly performed in great depth and in a cost-efficient manner. The 3DinvitroNPC project has exploited a 3-dimensional method of assessing the viability and functionality of nanoparticles for medical applications" Dr. Anna Laromaine explains in the article.

"The idea behind the project is that instead of evaluating nanoparticles on a 2D cell culture, we will develop a 3D cell culture and in vivo simple biological structures"

The core goal of the project is to develop a platform to test nanoparticles, based on Dr. Laromaine’s previous experience in developing 3D cell scaffolds. To this end, Dr. Laromaine and her team are using aerogels based on biodegradable polymers, and the model organism C. elegans.

With this project, they can address issues that are critical for the application of nanoparticles in biomedicine, such as toxicity or biodistribution of nanoparticles.

If you want to know more about this project, you can read the whole article here.

Also on ICMAB...

On 26 October 2018, Anna Laromaine participated in the project "Ciencia y Tecnología en femenino", organized by the Asociación de Parques Científicos y Tecnológicos de España (APTE) and with the suppo...

Biomaterials and materials for drug delivery, therapy, diagnostics and sensing

Dr. Anna Laromaine, from ICMAB-CSIC, and Dr. Núria Sánchez-Coll, from CRAG (Center for Research in Agricultural Genomics) have developed an effective method for plant tissue regeneration that involves...

The IES Pere Calders, at the Campus UAB, visited our Institute on November 17, during the Setmana de la Ciència (Science Week). More than 30 students between 16-18 years could visit some of our scient...